Clinical trials
Phase 2 Bone Diseases, Metabolic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 7 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Northwestern University | 4 |
| Odense University Hospital | 4 |
| Massachusetts General Hospital | 3 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| National Cancer Institute (NCI) | 2 |
| Novartis Pharmaceuticals | 2 |
| Thomas J. Schnitzer | 2 |
| Alexandria University | 1 |
| Azelon Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Diseases, Metabolic | 52 |
| Osteoporosis | 34 |
| Bone Diseases | 8 |
| Musculoskeletal Diseases | 6 |
| Spinal Cord Injuries | 6 |
| Osteoporosis, Postmenopausal | 5 |
| Fractures, Bone | 4 |
| Spinal Cord Diseases | 4 |
| Central Nervous System Diseases | 3 |
| HIV Infections | 3 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.